Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects

Tuberculosis

Volumn 92, Issue 5, 2012, Pages 397-403

  Kurbatova, Ekaterina V ^a   Taylor, Allison ^a   Gammino, Victoria M ^a   Bayona, Jaime ^b   Becerra, Mercedes ^b   Danilovitz, Manfred ^c   Falzon, Dennis ^d   Gelmanova, Irina ^a   Keshavjee, Salmaan ^b   Leimane, Vaira ^e   Mitnick, Carole D ^b   Quelapio, Ma Imelda ^f   Riekstina, Vija ^e   Viiklepp, Piret ^g   Zignol, Matteo ^d   Cegielski, J Peter ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TARTU UNIVERSITY HOSPITAL   (Estonia)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

^f Tropical Disease Foundation   (Philippines)

^g NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

Author keywords

Multidrug resistant tuberculosis; Risk factors; Treatment outcomes

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT; THIOAMIDE; TUBERCULOSTATIC AGENT;

ADULT; ALCOHOL ABUSE; ARTICLE; BACTERIUM CULTURE; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DIARRHEA; DRUG TREATMENT FAILURE; DRUG USE; ESTONIA; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HEADACHE; HEARING DISORDER; HEPATITIS; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOKALEMIA; HYPOTHYROIDISM; INFECTION RISK; INTRAVENOUS DRUG ABUSE; KIDNEY FAILURE; LATVIA; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; NAUSEA; OTOTOXICITY; PERIPHERAL NEUROPATHY; PERU; PHILIPPINES; PREDICTION; PRIORITY JOURNAL; PRISON; PSYCHOSIS; RUSSIAN FEDERATION; SEIZURE; SHORT COURSE THERAPY; SIDE EFFECT; SMEAR; SMOKING; TREATMENT OUTCOME; TUBERCULOSIS CONTROL; UNEMPLOYMENT;

ADULT; AGE FACTORS; ANTITUBERCULAR AGENTS; BODY MASS INDEX; DIRECTLY OBSERVED THERAPY; ESTONIA; FEMALE; HIV SEROPOSITIVITY; HUMANS; LATVIA; MALE; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); PERU; PHILIPPINES; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; RUSSIA; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84865514086     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2012.06.003     Document Type: Article

References (19)

1. World Health Organization The global plan to stop TB 2011-2015 Geneva, Switzerland 2011
2. J.C. Johnston, N.C. Shahidi, M. Sadatsafavi, and J.M. Fitzgerald Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis PLoS One 4 9 2009 e6914
3. E.W. Orenstein, S. Basu, N.S. Shah, J.R. Andrews, G.H. Friedland, A.P. Moll, N.R. Gandhi, and A.P. Galvani Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis Lancet Infect Dis 9 3 2009 153 161
4. World Health Organization Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency update 2008 Switzerland Geneva
5. E. Nathanson, C. Lambregts-van Weezenbeek, M.L. Rich, R. Gupta, J. Bayona, K. Blondal, J.A. Caminero, J.P. Cegielski, M. Danilovits, M.A. Espinal, V. Hollo, E. Jaramillo, V. Leimane, C.D. Mitnick, J.S. Mukherjee, P. Nunn, A. Pasechnikov, T. Tupasi, C. Wells, and M.C. Raviglione Multidrug-resistant tuberculosis management in resource-limited settings Emerg Infect Dis 12 9 2006 1389 1397 (Pubitemid 44455215)
6. V. Gammino, A. Taylor, M. Rich, J. Bayona, M. Becerra, C. Bonilla, I. Gelmanova, V. Hollo, E. Jaramillo, S. Keshavjee, V. Leimane, C. Mitnick, M. Quelapio, V. Riektsina, T. Tupasi, C. Wells, M. Zignol, and P. Cegielski Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects Int J Tuberc Lung Dis 15 10 2011 1315 1322
7. World Health Organization Guidelines for establishing DOTS-PLUS pilot projects for the management of multidrug-resistant tuberculosis (MDR-TB) 2000 Switzerland Geneva
8. K.F. Laserson, L.E. Thorpe, V. Leimane, K. Weyer, C.D. Mitnick, V. Riekstina, E. Zarovska, M.L. Rich, H.S. Fraser, E. Alarcon, J.P. Cegielski, M. Grzemska, R. Gupta, and M. Espinal Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis Int J Tuberc Lung Dis 9 6 2005 640 645 (Pubitemid 40826156)
9. World Health Organization Multidrug and extensively drug-resistant TB (M/XDR-TB) 2010 Global Report on Surveillance and response. Geneva, Switzerland 2010
10. C.J. Waitt, and S.B. Squire A systematic review of risk factors for death in adults during and after tuberculosis treatment Int J Tuberc Lung Dis 2011
11. T.H. Holtz, M. Sternberg, S. Kammerer, K.F. Laserson, V. Riekstina, E. Zarovska, V. Skripconoka, C.D. Wells, and V. Leimane Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome Ann Intern Med 144 9 2006 650 659 (Pubitemid 46780649)
12. V. Leimane, V. Riekstina, T.H. Holtz, E. Zarovska, V. Skripconoka, L.E. Thorpe, K.F. Laserson, and C.D. Wells Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study Lancet 365 9456 2005 318 326 (Pubitemid 40139109)
13. G.B. Migliori, C. Lange, E. Girardi, R. Centis, G. Besozzi, K. Kliiman, L.R. Codecasa, A. Spanevello, and D.M. Cirillo Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis? Eur Respir J 31 4 2008 904 905
14. W.M. Jakubowiak, E.M. Bogorodskaya, S.E. Borisov, I.D. Danilova, O.B. Lomakina, and E.V. Kourbatova Social support and incentives programme for patients with tuberculosis: experience from the Russian Federation Int J Tuberc Lung Dis 11 11 2007 1210 1215 (Pubitemid 350146302)
15. E. Bloss, L. Kuksa, T.H. Holtz, V. Riekstina, V. Skripconoka, S. Kammerer, and V. Leimane Adverse events related to multidrug-resistant tuberculosis treatment, Latvia, 2000-2004 Int J Tuberc Lung Dis 14 3 2010 275 281
16. E. Nathanson, R. Gupta, P. Huamani, V. Leimane, A.D. Pasechnikov, T.E. Tupasi, K. Vink, E. Jaramillo, and M.A. Espinal Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative Int J Tuberc Lung Dis 8 11 2004 1382 1384 (Pubitemid 39611587)
17. S.S. Shin, A.D. Pasechnikov, I.Y. Gelmanova, G.G. Peremitin, A.K. Strelis, S. Mishustin, A. Barnashov, Y. Karpeichik, Y.G. Andreev, V.T. Golubchikova, T.P. Tonkel, G.V. Yanova, A. Yedilbayev, M.L. Rich, J.S. Mukherjee, J.J. Furin, S. Atwood, P.E. Farmer, and S. Keshavjee Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia Int J Tuberc Lung Dis 11 12 2007 1314 1320
18. The Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB. Specific treatment parameters and treatment outcomes of multidrug-resistant tuberculosis: an individual patient data (IPD) meta-analysis of 9153 patients, in preparation.
19. World Health Organization Guidelines for the programmatic management of drug-resistant tuberculosis 2011 update. Geneva, Switzerland 2011